ArticleAlzheimer's & dementia (New York, N. Y.)2016

Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.

Nienke M E Scheltens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.